Precigen (PGEN) EBIT Margin (QoQ) (2012 - 2026)
Precigen (PGEN) EBIT Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,966.00 |
| Dec 31, 2025 | 338,496.00 |
| Sep 30, 2025 | 40,669.00 |
| Jun 30, 2025 | -238,208.00 |
| Mar 31, 2025 | -91,222.00 |
| Dec 31, 2024 | 212.54 Mn |
| Sep 30, 2024 | -211.77 Mn |
| Jun 30, 2024 | -619,348.00 |
| Mar 31, 2024 | 49,495.00 |
| Dec 31, 2023 | 209.09 Mn |
| Sep 30, 2023 | -209.25 Mn |
| Dec 31, 2022 | 20,192.00 |
| Sep 30, 2022 | 77,796.00 |
| Jun 30, 2022 | -42,819.00 |
| Mar 31, 2022 | -61,888.00 |
| Dec 31, 2021 | 86,301.00 |
| Sep 30, 2021 | 4,122.00 |
| Jun 30, 2021 | -61,502.00 |
| Mar 31, 2021 | 10,974.00 |
| Dec 31, 2020 | -8,435.00 |